Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
Uslu U, Da T, Assenmacher CA, Scholler J, Young RM, Tchou J, June CH. Sci Adv. 2023 Jan 13;9(2):eade2526. doi: 10.1126/sciadv.ade2526. Epub 2023 Jan 11
Summary
CAR T Cell Therapy May Eliminate Tumor Cells Missed by Surgery. Preclinical study sets up clinical trials of CAR T cell treatment following surgery for breast cancer.
Read the Penn Medicine news release
